137 related articles for article (PubMed ID: 16005851)
1. Group IB secretory phospholipase A2 stimulates leukotriene B4 production by a unique mechanism in human neutrophils.
Lee HY; Kim MK; Park KS; Shin EH; Bae YS
Biochem Biophys Res Commun; 2005 Aug; 334(2):500-8. PubMed ID: 16005851
[TBL] [Abstract][Full Text] [Related]
2. Group IB secretory phospholipase A2 stimulates CXC chemokine ligand 8 production via ERK and NF-kappa B in human neutrophils.
Jo EJ; Lee HY; Lee YN; Kim JI; Kang HK; Park DW; Baek SH; Kwak JY; Bae YS
J Immunol; 2004 Nov; 173(10):6433-9. PubMed ID: 15528384
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2.
Abe M; Matsuki H; Domae M; Kuwata H; Kudo I; Nakanishi Y; Hara N; Mitsuyama T; Furukawa T
Am J Respir Cell Mol Biol; 1996 Nov; 15(5):565-73. PubMed ID: 8918363
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming.
Bauldry SA; McCall CE; Cousart SL; Bass DA
J Immunol; 1991 Feb; 146(4):1277-85. PubMed ID: 1846897
[TBL] [Abstract][Full Text] [Related]
5. The influence of acetylshikonin, a natural naphthoquinone, on the production of leukotriene B4 and thromboxane A2 in rat neutrophils.
Hsu MF; Chang LC; Huang LJ; Kuo SC; Lee HY; Lu MC; Wang JP
Eur J Pharmacol; 2009 Apr; 607(1-3):234-43. PubMed ID: 19232341
[TBL] [Abstract][Full Text] [Related]
6. Adenosine. An endogenous inhibitor of arachidonic acid release and leukotriene biosynthesis in human neutrophils.
Krump E; Borgeat P
Adv Exp Med Biol; 1999; 447():107-15. PubMed ID: 10086187
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene B4 stimulates the release of arachidonate in human neutrophils via the action of cytosolic phospholipase A2.
Burke JR; Davern LB; Gregor KR; Tramposch KM
Biochim Biophys Acta; 1997 Oct; 1359(1):80-8. PubMed ID: 9398088
[TBL] [Abstract][Full Text] [Related]
8. Differential production of leukotriene B4 or prostaglandin E2 by WKYMVm or serum amyloid A via formyl peptide receptor-like 1.
Lee HY; Jo SH; Lee C; Baek SH; Bae YS
Biochem Pharmacol; 2006 Sep; 72(7):860-8. PubMed ID: 16859643
[TBL] [Abstract][Full Text] [Related]
9. Presence of the M-type sPLA(2) receptor on neutrophils and its role in elastase release and adhesion.
Silliman CC; Moore EE; Zallen G; Gonzalez R; Johnson JL; Elzi DJ; Meng X; Hanasaki K; Ishizaki J; Arita H; Ao L; England KM; Banerjee A
Am J Physiol Cell Physiol; 2002 Oct; 283(4):C1102-13. PubMed ID: 12225974
[TBL] [Abstract][Full Text] [Related]
10. BIRM 270: a novel inhibitor of arachidonate release that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils.
Farina PR; Graham AG; Hoffman AF; Watrous JM; Borgeat P; Nadeau M; Hansen G; Dinallo RM; Adams J; Miao CK
J Pharmacol Exp Ther; 1994 Dec; 271(3):1418-26. PubMed ID: 7996454
[TBL] [Abstract][Full Text] [Related]
11. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400
[TBL] [Abstract][Full Text] [Related]
12. Exogenous leukotriene B4 (LTB4) inhibits human neutrophil generation of LTB4 from endogenous arachidonic acid during opsonized zymosan phagocytosis.
Fiedler J; Wheelan P; Henson PM; Murphy RC
J Pharmacol Exp Ther; 1998 Oct; 287(1):150-6. PubMed ID: 9765334
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandins inhibit 5-lipoxygenase-activating protein expression and leukotriene B4 production from dendritic cells via an IL-10-dependent mechanism.
Harizi H; Juzan M; Moreau JF; Gualde N
J Immunol; 2003 Jan; 170(1):139-46. PubMed ID: 12496393
[TBL] [Abstract][Full Text] [Related]
14. Calcium-dependent eicosanoid metabolism by concanavalin A-stimulated human monocytes in vitro. Synergism with phorbol ester indicates separate regulation of leukotriene B4 synthesis and release.
Hoffman T; Brando C; Lizzio EF; Lee YL; Hansen M; Tripathi AK; Taplits M; Puri J; Bonvini E; Abrahamsen TG
J Immunol; 1991 Jan; 146(2):692-700. PubMed ID: 1846160
[TBL] [Abstract][Full Text] [Related]
15. The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate.
Schröder JM
J Exp Med; 1989 Sep; 170(3):847-63. PubMed ID: 2549166
[TBL] [Abstract][Full Text] [Related]
16. Insoluble immune complex-stimulated neutrophil leukotriene B4 production is dependent on Fc gamma RII and Fc gamma RIII and independent of pertussis toxin-sensitive signal transduction pathways.
Crockett-Torabi E; Smith CW; Kateley JR; Patterson R; Tsai P; Fantone JC
Am J Pathol; 1992 Mar; 140(3):613-20. PubMed ID: 1312307
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the production of platelet activating factor and of leukotriene B4 in activated neutrophils by nimesulide due to an elevation of intracellular cyclic adenosine monophosphate.
Tool AT; Verhoeven AJ
Arzneimittelforschung; 1995 Oct; 45(10):1110-4. PubMed ID: 8595070
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of type II phospholipase A2 and platelet-activating factor on Mac-1 surface expression and exocytosis of gelatinase granules in human neutrophils: evidence for the 5-lipoxygenase-dependent mechanism.
Takasaki J; Kawauchi Y; Masuho Y
J Immunol; 1998 May; 160(10):5066-72. PubMed ID: 9590257
[TBL] [Abstract][Full Text] [Related]
19. Phospholipase A2 as leukotriene B4 secretagogue for human polymorphonuclear leukocytes.
Lam BK; Yang CY; Wong PY
Adv Exp Med Biol; 1990; 275():183-91. PubMed ID: 2173367
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase A2 activation in human neutrophils requires influx of extracellular Ca2+ and leukotriene B4.
Reddy S; Bose R; Rao GH; Murthy M
Am J Physiol; 1995 Jan; 268(1 Pt 1):C138-46. PubMed ID: 7840141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
